Time waits for no man: deciding when to file a patent application in Europe.
作者信息
White Nina L
机构信息
Boult Wade Tennant, Verulam Gardens, 70 Gray's Inn Road, London WC1X 8BT, UK.
出版信息
Nat Biotechnol. 2007 Jun;25(6):639-41. doi: 10.1038/nbt0607-639.
PMID:17557096
Abstract
摘要
相似文献
1
Time waits for no man: deciding when to file a patent application in Europe.
Nat Biotechnol. 2007 Jun;25(6):639-41. doi: 10.1038/nbt0607-639.
2
The level of disclosure necessary for patent protection of genetic innovations.
Nat Biotechnol. 2004 Oct;22(10):1307-8. doi: 10.1038/nbt1004-1307.
3
Determining the meaning of claim terms.
Nat Biotechnol. 2006 Jan;24(1):41-3. doi: 10.1038/nbt0106-41.
4
Patents: patenting of stem cell related inventions in Europe.
Biotechnol J. 2006 Apr;1(4):384-7. doi: 10.1002/biot.200600021.
5
Enzo Biochem v. Gen-Probe: complying with the written description requirement under US patent law.
Nat Biotechnol. 2003 Jan;21(1):97-9. doi: 10.1038/nbt0103-97.
6
Errors in patent application sequence listings.
Nat Biotechnol. 2003 Oct;21(10):1239-40. doi: 10.1038/nbt1003-1239.
7
Is the viability of the Lilly doctrine on the decline?
Nat Biotechnol. 2003 Aug;21(8):943-4. doi: 10.1038/nbt0803-943.
8
The 'Lilly doctrine' is viable and critical.
Nat Biotechnol. 2003 Oct;21(10):1131-2. doi: 10.1038/nbt1003-1131b.
9
A level playing field for intellectual property enforcement.
Med Device Technol. 2004 May;15(4):11.
10
Publish and perish: what constitutes a bar under the patent laws.
Nat Biotechnol. 2004 Nov;22(11):1449-51. doi: 10.1038/nbt1104-1449.
Zotero 插件